The global orthopaedic oncology
market is segmented into treatment such as surgery, chemotherapy, radiation
therapy and targeted therapy. Among these segments, surgery segment is expected
to occupy the top position in the market. Increasing number of musculoskeletal
oncology is anticipated to impel the growth of the orthopaedic oncology surgery
market. Further, robust development of healthcare infrastructure bodes well for
the growth of orthopaedic oncology surgery market. Surgery segment is further
sub segmented into amputation, limb salvage surgery and reconstructive surgery.
Global orthopaedic oncology market
is expected to flourish at a significant CAGR over the forecast period. Factors
such as increasing healthcare spending, rising number of bone and joint cancer patients,
favorable government initiatives and increasing disposable income of the
population are anticipated to drive the growth of the orthopaedic
oncology market. Further, evolution of advanced and precision
oncology is likely to drive the future adoption of orthopaedic oncology. Moreover,
the global orthopaedic oncology market is projected to garner noteworthy
revenue by the end of 2024.
In the regional segment, North
America represented the largest market for orthopaedic oncology worldwide in
2016. This can be attributed to the rise in the number of musculoskeletal and
cancer related disorders in the region. Asia Pacific is projected to showcase
substantial growth in orthopaedic oncology market during the forecast period on
the account of rising awareness and increasing per capita income. Further,
strong growth in the development of healthcare infrastructure is opening a
gateway of opportunities for the growth of the orthopaedic oncology market in
Asia Pacific. Europe orthopaedic oncology market is a prominent regional market
and is likely to showcase lucrative growth during the forecast period.
Increasing Cases of
Musculoskeletal Tumours
Rapid ageing old age population coupled with
increasing cases of soft tissues and bones tumour is anticipated to drive the impel
the growth of the orthopaedic oncology market during the forecast period. For
instance, according to U.S. Department of Health and Human Services, the number
of new bone and joint cancer cases was estimated to be 3,260 and 1,550 people
were estimated to die of this disease in U.S.
Growing Research
and Development Activities
Innovations and advancement in orthopaedic
oncology is making headway for the growth of the global orthopaedic oncology
market. Apart from this, government policies and awareness programs are
anticipated to foster the growth of global orthopaedic oncology market.
Although, high cost of
treatment and therapies and lack of awareness are some of the factors that are
likely to inhibit the growth of the global orthopaedic oncology market in the
near future.
The report titled “Orthopaedic Oncology Market
: Global Historical Growth
(2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity
Evaluation” delivers detailed overview of the global orthopaedic
oncology market in terms of market segmentation by treatment, by end user and
by region.
Further, for the in-depth analysis, the report encompasses
the industry growth drivers, restraints, supply and demand risk, market
attractiveness, BPS analysis and Porter’s five force model.
This report also provides the
existing competitive scenario of some of the key players of the global orthopaedic
oncology market which includes company profiling of Stryker Corporation, Amgen
Inc., Creganna Medical Group, Accentus Inc., Canon Medical Systems, Siemens
Healthineers, MD Anderson Cancer Center, F. Hoffmann-La Roche Ltd., Novartis AG
and Sanofi S.A. The profiling enfolds key information of the companies which
encompasses business overview, products and services, key financials and recent
news and developments. On the whole, the report depicts detailed overview of
the global orthopaedic oncology market that will help industry consultants,
equipment manufacturers, existing players searching for expansion
opportunities, new players searching possibilities and other stakeholders to
align their market centric strategies according to the ongoing and expected
trends in the future.
About Research
Nester
Research Nester is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision so as to avoid future uncertainties.
Read more Information: https://www.researchnester.com/reports/orthopaedic-oncology-market/579
Contact for more
Info:
Ajay
Daniel
U.S.
+1 646 586 9123
U.K.
+44 203 608 5919